Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank
Collister JA., Liu X., Littlejohns TJ., Cuzick J., Clifton L., Hunter DJ.
Breakdown of case and control classification in the test data (N = 25,369) using 10-year risks from the Tyrer-Cuzick model with and without PRSBC, with a fixed proportion (6.47%) of women considered at “moderate risk”.